| Kennebunk Center For Health & Rehabilitation, Llc | |
| 158 Ross Rd, Kennebunk, Maine 04043 | |
| (207) 985-7141 | |
| Name | Kennebunk Center For Health & Rehabilitation, Llc |
|---|---|
| Location | 158 Ross Rd, Kennebunk, Maine |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 78 |
| Occupancy Rate | 72.18% |
| Medicare ID (CCN) | 205095 |
| Legal Business Name | Vk Kennebunk Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1568859783 |
| Address | 158 Ross Rd, Kennebunk, ME 04043 |
| Phone Number | 207-590-9449 |
News Archive
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.
A Canadian study conducted at Robarts Research Institute sheds new light on how poxviruses can jump from species to species - and will lead to further exploration of another potential candidate in the emerging field of "oncolytic viruses" to fight cancer.
Blue Shield of California today announced the signing of a new, two-year contract with Sutter Health. Blue Shield is pleased to offer members access to Sutter Health providers and facilities as participating providers effective February 1, 2015 through December 31, 2016. Blue Shield apologizes that the contract negotiation took longer than expected and that customers and members experienced uncertainty or disruption.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
› Verified 7 days ago
| NPI Number | 1780924191 |
| Organization Name | VK KENNEBUNK, LLC |
| Doing Business As | KENNEBUNK CENTER FOR HEALTH & REHABILITATION LLC |
| Address | 158 Ross Rd, Kennebunk, ME 04043 |
| Phone Number | 207-985-7141 |
News Archive
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.
A Canadian study conducted at Robarts Research Institute sheds new light on how poxviruses can jump from species to species - and will lead to further exploration of another potential candidate in the emerging field of "oncolytic viruses" to fight cancer.
Blue Shield of California today announced the signing of a new, two-year contract with Sutter Health. Blue Shield is pleased to offer members access to Sutter Health providers and facilities as participating providers effective February 1, 2015 through December 31, 2016. Blue Shield apologizes that the contract negotiation took longer than expected and that customers and members experienced uncertainty or disruption.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.
A Canadian study conducted at Robarts Research Institute sheds new light on how poxviruses can jump from species to species - and will lead to further exploration of another potential candidate in the emerging field of "oncolytic viruses" to fight cancer.
Blue Shield of California today announced the signing of a new, two-year contract with Sutter Health. Blue Shield is pleased to offer members access to Sutter Health providers and facilities as participating providers effective February 1, 2015 through December 31, 2016. Blue Shield apologizes that the contract negotiation took longer than expected and that customers and members experienced uncertainty or disruption.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $6633 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 6.02 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.49 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 61.8 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.37 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.16 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 11.83 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.48 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 87.62 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.71 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.82 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.56 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 22.67 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.88 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.49 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.73 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 73.08 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 78.02 | 82.93 |
News Archive
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.
A Canadian study conducted at Robarts Research Institute sheds new light on how poxviruses can jump from species to species - and will lead to further exploration of another potential candidate in the emerging field of "oncolytic viruses" to fight cancer.
Blue Shield of California today announced the signing of a new, two-year contract with Sutter Health. Blue Shield is pleased to offer members access to Sutter Health providers and facilities as participating providers effective February 1, 2015 through December 31, 2016. Blue Shield apologizes that the contract negotiation took longer than expected and that customers and members experienced uncertainty or disruption.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
› Verified 7 days ago
Kennebunk Center For Health & Rehabilitation, Llc Location: 158 Ross Rd, Kennebunk, Maine 04043 Phone: (207) 985-7141 |